FindTrial
Sign In

Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

Clinical Study Evaluating the Efficacy of Chloroquine or Hydroxychloroquine in COVID-19 Treatment

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04353336
Enrollment
194
Registered
2020-04-20
Start date
2020-03-23
Completion date
2020-07-01
Last updated
2021-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Coronavirus Infection

Brief summary

Chloroquine or hydroxychloroquine in COVID-19 treatment

Detailed description

Clinical Study Evaluating the Efficacy of Chloroquine or hydroxychloroquine in COVID-19 treatment

Interventions

DRUGChloroquine or Hydroxychloroquine

Chloroquine or Hydroxychloroquine

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Covid 19 patients

Exclusion criteria

* Allergy or contraindication to the drug * Pregnant or lactating * Patients with cardiac problems

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with cure or death1 monththe number of patients with cure or death

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026